Neurology

Enterovirus D-68
Health

New evidence points to possible cause of puzzling paralysis in kids

By Maggie Fox

Football 1961
Health

Former NFL players die at a faster rate than other professional athletes, study finds

By Shraddha Chakradhar

Brain cancer
Biotech

Tocagen continues a brain cancer gene therapy clinical trial. Investors fear the worst

By Adam Feuerstein

brainHQ training screenshot
Health

Brain training shows promise as a treatment for veterans’ cognitive problems after TBI

By Sharon Begley

Mouse Brain colorized
In the Lab

By disabling a protein in the brain’s blood vessels, researchers ease age-related deterioration in mice

By Andrew Joseph

Spinraza injection
Biotech

Your guide to the mounting competition among new SMA drugs

By Damian Garde and Adam Feuerstein

Pharmalot

Pharmalittle: Pfizer prices new rare disease drug at $225,000; Novartis pushes gene therapy

By Ed Silverman

Cytokinetics
Biotech

Cytokinetics pushes ahead with ALS drug despite negative clinical trial outcome

By Adam Feuerstein

Jackson Moore
Biotech

Scientists see hope in a rare disease drug Wall Street has all but written off

By Damian Garde

MS medication
Pharmalot

To the moon: Out-of-pocket costs for multiple sclerosis medicines have skyrocketed

By Ed Silverman

FDA room
Pharmalot

Advocacy group sues FDA for failing to issue warnings on Parkinson’s drugs about compulsive behaviors

By Ed Silverman

Neurons
Biotech

For Dan Doctoroff, funding ALS research is a family matter

By Jonathan Saltzman — Boston Globe

ECoG Electrode Array
In the Lab

Virtual vocal tract creates speech from brain signals, a potential aid for ALS and stroke patients

By Sharon Begley

Duchenne muscular dystrophy Histopathology
Biotech

Audentes Therapeutics to develop gene therapies for two types of muscular dystrophy, including Duchenne

By Matthew Herper

Jaenisch-Liu
In the Lab

In STAT Madness, CRISPR tools to treat brain disorders capture Editors’ Pick

By Sharon Begley

Teen Juul
Health

FDA is investigating reports of seizures after vaping

By Megan Thielking

Health

When the ‘real thing’ becomes a mirage: How patients in Alzheimer’s trials are coping with the treatment’s failure

By Andrew Joseph

Dentate gyrus neurons
In the Lab

Old brains still make neurons, study finds, offering a possible way to protect against Alzheimer’s

By Sharon Begley

In the Lab

By decoding flickering brain signals, scientists envision a new way to detect consciousness

By Eric Boodman

Blood plasma sample
In the Lab

In a field full of failures, a new blood test to predict Alzheimer’s aims to give drug makers a needed tool

By Sharon Begley

Pharmalot

Pharmalittle: Roche halts Alzheimer’s drug trials; is public health jeopardized as FDA fast tracks generics?

By Ed Silverman

Sanofi Genzyme Boston
Biotech

Sanofi-Genzyme inappropriately sought confidential patient information, suit alleges

By Kate Sheridan

Glioblastoma Cells
In the Lab

In small studies, cancer vaccines generate immune responses against brain tumors

By Andrew Joseph

Dementia
In the Lab

Tests used to determine if someone needs dementia evals are riddled with bias, study finds

By Eric Boodman

Exhaust pipe
Health

Exposure to air pollution during pregnancy or early life linked to autism diagnosis

By Karen Weintraub

Brain neurons
Biotech

A pharma veteran best known for biotech reflects on leading a startup, pricing a drug, and investing in politics

By Adam Feuerstein, Damian Garde, and Rebecca Robbins

Pill stomach
Biotech

Sick of a daily pill? A Boston biotech wants to make a daily Alzheimer’s drug last for a week — and they’re working on more

By Kate Sheridan

STAT Brain Signals Final GIF
In the Lab

With brain implants, scientists hope to translate paralyzed patients’ thoughts into speech

By Sharon Begley

Alzheimers Association
In the Lab

New prize offers $2 million for finding key to Alzheimer’s in past research

By Sharon Begley

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy